Fabomotizole
| Fabomotizole | |
|---|---|
| Salts [] | |
|---|---|
| Fabomotizole hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 307.40 g/mol [1] |
| Predicted LogP | 2.3 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C15H21N3O2S |
| IUPAC name | 4-[2-[(6-ethoxy-1H-benzimidazol-2-yl)sulfanyl]ethyl]morpholine |
| SMILES | CCOC1=CC2=C(C=C1)N=C(N2)SCCN3CCOCC3 |
| InChI | InChI=1S/C15H21N3O2S/c1-2-20-12-3-4-13-14(11-12)17-15(16-13)21-10-7-18-5-8-19-9-6-18/h3-4,11H,2,5-10H2,1H3,(H,16,17) |
| InChIKey | WWNUCVSRRUDYPP-UHFFFAOYSA-N |
| CAS number | 173352-21-1 |
| UNII | 0F8K1X115C |
| PubChem CID | 9862937 |
| Pharmacokinetics[] | |
|---|---|
| Onset | 0.85±0.13 hours |
| Elimination half-life | 0.82±0.54 hours |
| Metabolism | extensive hepatic |
| Routes of administration | Oral |
Fabomotizole (also known as Afobazole, Obenoxazine, Aphobazole, fabomotizol, Cm-346, 5-Ethoxy-2-((2-(morpholin-4-yl)ethyl)sulfanyl)-1H-benzimidazole, 5-ethoxy-2-{[2-(morpholin-4-yl)ethyl]sulfanyl}-1h-1,3-benzodiazole, 1h-benzimidazole, 5-ethoxy-2-((2-(4-morpholinyl)ethyl)thio)-, fabomotizolum or 5-ethoxy-2-((2-(morpholin-4-yl)ethyl)sulfanyl)-1H-1,3-benzodiazole) is a substance of the phenol and benzimidazole class.
Chemistry
Salts []
Fabomotizole is typically found in the form of its hydrochloride salt.
Stereochemistry []
Fabomotizole is achiral.
Druglikeness
Lipinski's rule of five
Fabomotizole matches Lipinski's rule of five.Pharmacology
ATC Classification
- nervous system (N)
- psycholeptics (N05)
- anxiolytics (N05B)
- other anxiolytics (N05BX)
- fabomotizole (N05BX04)
Legal status []
- United States: Fabomotizole is a unscheduled Not FDA approved.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 9862937, Fabomotizole. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/9862937
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Fabomotizole. UNII: 0F8K1X115C. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/0F8K1X115C
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 11:40:52 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 11:40:48 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 11:40:48 |
| gsrs | ok | 2026-11-20 11:40:49 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0252156) | 2026-11-20 11:40:48 |
| kegg | ok | 2026-11-20 11:40:49 |
| pubchem | ok | 2026-11-20 11:40:47 |
| missing (no r/tripreports posts mention it) | 2026-11-20 11:40:48 | |
| sider | missing (not in SIDER) | 2026-11-20 11:40:48 |
| structure | ok | 2026-11-20 11:40:48 |
| wikipedia | ok | 2026-11-20 11:40:48 |